General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Expected to Earn FY2024 Earnings of ($4.50) Per Share | news.google.com • |
Intellia (NTLA) Up on Positive Data Updates From HAE Study | news.google.com • |
Does Intellia Therapeutics (NASDAQ:NTLA) Have A Healthy Balance Sheet? | news.google.com • |
6747 Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA) Acquired by Vanguard Personalized Indexing Management ... | news.google.com • |
3 Of My Favorite Names On Wells Fargo's Biotech Buyout List | seekingalpha.com • |
Intellia Therapeutics (NASDAQ:NTLA) Trading Down 3.6% | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -1.35 | -1.06 | 0.29 | 21.48% |
2024-02-22 | 2023-12 | -1.47 | -1.46 | 0.01 | 0.68% |
2023-11-09 | 2023-09 | -1.52 | -1.38 | 0.14 | 9.21% |
2023-08-03 | 2023-06 | -1.32 | -1.4 | -0.08 | -6.06% |
2023-05-04 | 2023-03 | -1.41 | -1.17 | 0.24 | 17.02% |
2023-02-23 | 2022-12 | -1.4 | -1.4 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-28 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-06 | Chardan Capital | Upgrade | Buy | Buy |
2023-08-06 | Canaccord Genuity | Upgrade | Buy | Buy |
2023-08-06 | Barclays | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-03 | BASTA JAMES EDMUND | General Counsel | 81.57K | Sale |
2023-10-30 | BHANJI MUNA | Director | 12.00K | Sale |
2024-03-03 | CLARK ELIANA | Chief Technology Officer | 71.47K | Sale |
2023-06-13 | COHEN FREDERICK E. M.D. PH.D. | Director | 41.72K | Stock Award(Grant) |
2023-06-13 | CROWLEY JOHN FRANCIS | Director | 11.72K | Stock Award(Grant) |
2024-02-29 | GODDARD GLENN G | Chief Financial Officer | 69.21K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | ARK Investment Management, LLC | 9.95M | 314.58M | 11.24% |
2023-06-29 | Vanguard Group Inc | 8.19M | 333.79M | 9.25% |
2023-06-29 | Blackrock Inc. | 8.05M | 328.48M | 9.10% |
2023-06-29 | State Street Corporation | 3.49M | 142.44M | 3.95% |
2023-06-29 | Nikko Asset Management Americas, Inc. | 3.39M | 138.43M | 3.84% |
2023-06-29 | Sumitomo Mitsui Trust Holdings, Inc. | 3.39M | 138.43M | 3.84% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | ARK ETF Tr-ARK Innovation ETF | 6.78M | 214.49M | 7.67% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.62M | 107.02M | 2.97% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.16M | 88.16M | 2.44% |
2023-09-29 | ARK ETF Tr-ARK Genomic Revolution ETF | 2.03M | 64.22M | 2.30% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 75.44M | 2.27% |
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.62M | 60.77M | 1.83% |
and I was right when I told you yesterday Nasdaq gonna be solid green today!
$NTLA price projection above $400 in 2022 by long term analysts, as company makes break thru in gene deletion therapies. Solid buy & hold as price action moves above $250 in July.️️️️
It’s not bleeding, most folks away on July 4th vacation. Some will quit their day by noon, it’s going to be a slow Friday. But shorts will cover at power hour!
So looked into sales/times since 9:30 on all exchanges & guess what, no one is selling! Mostly buys & only one large position of 31,000 or so around 9:30. Can someone confirm this? Pls
It’s moving down to hit stop loss orders! Remove all stop loss & set high sell limits my friends
Today you will see shorts covering to take profits before long wknd. Don’t be afraid if price dips, set higher sell limits & remove all sell loss orders
@mcdeez my thoughts exactly! All those investors & institutions are long term buyers. Won’t be a scalping like average Joe.
Time to destroy the bears
They will shit in their pants
Have to cover today
Tickeron has a positive outlook on this ticker $NTLA and predicts a further increase by more than 4.00% within the next month with a likelihood of 51%. During the last month, the daily ratio of advancing to declining volumes was 14.19 to 1.
Tickeron has a positive outlook on this ticker $NTLA and predicts a further increase by more than 4.00% within the next month with a likelihood of 51%. During the last month, the daily ratio of advancing to declining volumes was 14.19 to 1.
Offering is an old news! Happened 3 days ago. Won’t affect current price. $NTLA will only go high & higher and break $250 tomorrow.
F@&k all bears & shorters! They will lose money thru nostrils tomorrow You apes did well today! Same thing tomorrow buy & hold …no stop loss limits, and set sell price.
The news from Intellia sparked interest in several other companies working on similar gene-editing therapies.
$NTLA saw several days of gains in the wake of the results. It reached an all-time peak of $202.73, early Wednesday, before moderating a bit. On Thursday, the stock gained 6%.
@Abu falafel …When bulls own it @$250 tomorrow, you & rest of shorters will be flip flopping falafels
Closed $10 higher than yesterday sell offTomorrow will open $25 higher & with solid Nasdaq will cross into $250come join & buy now before it blows again!!!
@JD you R f’ed for shorting! It will never crash. Will cross $250 by tomorrow ️️️️